Marc Disabella
Neurology with Special Qualifications in Child Neurology · Washington, DCNPI 1013113075
Payments from drug & device makers
What this record shows
That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in DC, where the typical reported total is $298.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 110 payments — averaging $7123.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$533K
- Pfizer$138K
- Biohaven Pharmaceutical Holding Company Ltd.$49K
- Eli Lilly$42K
- H. Lundbeck A S$11K
- Supernus Pharmaceuticals, Inc.$10K
How this compares
$0 in reported general payments places this provider in the 5th percentile of 26 neurology with special qualifications in child neurology providers in District of Columbia.
See all neurology with special qualifications in child neurology providers in District of Columbia →
Other neurology with special qualifications in child neurology in Washington
- Sarah WrightWashington$53K
- John SchreiberWashington$45K
- Andrea GropmanWashington$36K
- Benjamin SiegelWashington$5K
- Laura TochenWashington$2K
- Stephen SharpWashington$959
- Melanie OrtizWashington$796
- Mejdi NajjarWashington$620
- Tarannum LateefWashington$600
- Meaghan KellyWashington$459
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.